(Q38378032)

2 September 2017

1 reference

title

British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases (English)

1 reference

2 September 2017

1 reference

0 references

7

1 reference

2 September 2017

5

Sebastian B Lucas

1 reference

2 September 2017

Silke Schelenz

1

1 reference

2 September 2017

Rosemary A Barnes

2

1 reference

2 September 2017

Richard C Barton

3

1 reference

2 September 2017

Joanne R Cleverley

4

1 reference

2 September 2017

Christopher C Kibbler

6

1 reference

2 September 2017

British Society for Medical Mycology

8

1 reference

2 September 2017

publication date

12 March 2015

1 reference

Lancet Infectious Diseases

2 September 2017

published in

1 reference

2 September 2017

volume

15

1 reference

2 September 2017

issue

4

1 reference

2 September 2017

page(s)

461-474

1 reference

Epidemiology of invasive mycoses in North America

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005–2007)

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Management of candidiasis in the intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Frequency, diagnosis and management of fungal respiratory infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Factors associated with overall and attributable mortality in invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Epidemiology of invasive fungal diseases on the basis of autopsy reports

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Fungal diagnosis: how do we do it and can we do better?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Standards of care for patients with invasive fungal infections within the United Kingdom: a national audit

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Audit of laboratory mycology services for the management of patients with fungal infections in the northwest of England

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Stage-specific manifestation of mold infections in bone marrow transplant recipients: risk factors and clinical significance of positive concentrated smears.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Specimen volume versus yield in the BACTEC blood culture system.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Use of fungal blood cultures in an academic medical center

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Evaluation of PNA-FISH yeast traffic light for rapid identification of yeast directly from positive blood cultures and assessment of clinical impact.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Evaluation of the peptide nucleic acid fluorescence in situ hybridisation technology for yeast identification directly from positive blood cultures: an Italian experience

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Multicenter evaluation of the Candida albicans/Candida glabrata peptide nucleic acid fluorescent in situ hybridization method for simultaneous dual-color identification of C. albicans and C. glabrata directly from blood culture bottles

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Allergic broncho-pulmonary aspergillosis. Clinical immunology. 2. Skin, nasal and bronchial tests

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Prediction of invasive pulmonary aspergillosis from colonisation of lower respiratory tract before marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: Guidelines of the infectious diseases working party of the German Society of Haematology and Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Pneumocystis carinii pneumonia in patients being registered for smear-negative pulmonary tuberculosis in Malawi.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Induced sputum for diagnosing Pneumocystis carinii pneumonia in HIV patients: new data, new issues

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Pneumocystis carinii Pneumonia: A Comparison Between Patients with the Acquired Immunodeficiency Syndrome and Patients with Other Immunodeficiencies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Near-universal prevalence of Pneumocystis and associated increase in mucus in the lungs of infants with sudden unexpected death.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Postgraduate institute management protocol for invasive Aspergillus flavus sinusitis: is it effective?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

The role of cryptococcal antigen assay in diagnosis and monitoring of cryptococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

The central nervous system and infection by Candida species

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Detection of Candida casts in experimental renal candidiasis: implications for the diagnosis and pathogenesis of upper urinary tract infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Management of invasive pulmonary aspergillosis in hematology patients: a review of 87 consecutive cases at a single institution

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Epidemiology and outcome of zygomycosis: a review of 929 reported cases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Evaluation of an indirect fluorescent-antibody stain for detection of Pneumocystis carinii in respiratory specimens

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

The epidemiological features and laboratory results of fungal keratitis: a 10-year review at a referral eye care center in South India

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Comparison of diagnostic methods in the evaluation of onychomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Detection of Pneumocystis carinii in tracheal aspirates of intubated patients using calcofluor-white (Fungi-Fluor) and immunofluorescence antibody (Genetic Systems) stains

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Detection of Pneumocystis jiroveci in respiratory specimens by four staining methods

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Immunodetection of Pneumocystis carinii in bronchoalveolar lavage specimens compared with methenamine silver stain.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Rapid detection of Pneumocystis carinii using a direct fluorescent monoclonal antibody stain

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Validation of the MycAssay Pneumocystis kit for detection of Pneumocystis jirovecii in bronchoalveolar lavage specimens by comparison to a laboratory standard of direct immunofluorescence microscopy, real-time PCR, or conventional PCR.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

PCR diagnosis of Pneumocystis pneumonia: a bivariate meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Cytology of treated and minimalPneumocystis carinii pneumonia and a pitfall of the grocott methenamine silver stain

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Utility of reflex Gomori methenamine silver staining for Pneumocystis jirovecii on bronchoalveolar lavage cytologic specimens: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

The diagnosis of Pneumocystis carinii pneumonia by cytologic evaluation of Papanicolaou and Leishman-stained bronchoalveolar specimens in patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Comparison of Papanicolaou's Stain with the Gomori Methenamine Silver (GMS) Stain for the Cytodiagnosis of Pneumocystis carinii in Bronchoalveolar Lavage (BAL) Fluid

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Monoclonal antibody to Pneumocystis carinii. Comparison with silver stain in bronchial lavage specimens

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Epidemiologic, clinical, and diagnostic aspects of coccidioidomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Rapid diagnostic evaluation of bronchial washings in patients with suspected coccidioidomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Eight-year study of allergic bronchopulmonary aspergillosis in an Indian teaching hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Aspergillosis in 25 renal transplant patients. Epidemiology, clinical presentation, diagnosis, and management.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Diagnosis of pulmonary infection caused by Aspergillus: usefulness of respiratory cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Aspergillus species isolated from clinical specimens: suggested clinical and microbiological criteria to determine significance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Efficacy and safety of posaconazole for chronic pulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Candida urinary tract infections--epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Performance of cryptococcus antigen latex agglutination kits on serum and cerebrospinal fluid specimens of AIDS patients before and after pronase treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Diagnosis of cryptococcal meningitis. Value of immunologic detection of cryptococcal antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Genotype prevalence and risk factors for severe clinical adenovirus infection, United States 2004-2006.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Diagnosis and management of central nervous system histoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Clinically driven diagnostic antifungal approach in neutropenic patients: a prospective feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Evaluation of three commercial latex agglutination kits and a commercial enzyme immunoassay for the detection of cryptococcal antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Evaluation of a newly developed lateral flow immunoassay for the diagnosis of cryptococcosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Galactomannan detection for invasive aspergillosis in immunocompromized patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Diagnosis of invasive aspergillosis in lung transplant recipients by detection of galactomannan in the bronchoalveolar lavage fluid.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Comparison of an Aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalvelolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Galactomannan in Bronchoalveolar Lavage Fluid

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

False positivity of the Aspergillus galactomannan Platelia ELISA because of piperacillin/tazobactam treatment: does it represent a clinical problem?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Piperacillin/tazobactam (Tazocin™) seems to be no longer responsible for false-positive results of the galactomannan assay

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Diagnostic accuracy of serum 1,3-β-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Evaluation of a newly developed down-flow immunoassay for detection of serum mannan antigens in patients with candidaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Serologic diagnosis of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis through the detection of immunoglobulin G to Aspergillus fumigatus.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

A consensus on fungal polymerase chain reaction diagnosis?: a United Kingdom-Ireland evaluation of polymerase chain reaction methods for detection of systemic fungal infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Aspergillus PCR: one step closer to standardization.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Evaluation of Aspergillus PCR protocols for testing serum specimens

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Homogenisation of cystic fibrosis sputum by sonication — An essential step for Aspergillus PCR

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

High-frequency triazole resistance found In nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Multicenter, prospective clinical evaluation of respiratory samples from subjects at risk for Pneumocystis jirovecii infection by use of a commercial real-time PCR assay

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Prevention and diagnosis of invasive fungal disease in high-risk patients within an integrative care pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Combined real-time PCR and galactomannan surveillance improves diagnosis of invasive aspergillosis in high risk patients with haematological malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Multicenter comparison of serum and whole-blood specimens for detection of Aspergillus DNA in high-risk hematological patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Evaluation of real-time PCR, galactomannan enzyme-linked immunosorbent assay (ELISA), and a novel lateral-flow device for diagnosis of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Effect of fluconazole prophylaxis on fungal blood cultures: an autopsy-based study involving 720 patients with haematological malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Antifungal treatment affects the laboratory diagnosis of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Oropharyngeal samples for genotyping and monitoring response to treatment in AIDS patients with Pneumocystis carinii pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Post-diagnostic kinetics of the (1 → 3)-β-D-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Performance of two Aspergillus IgG EIA assays compared with the precipitin test in chronic and allergic aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Evaluation of caspofungin susceptibility testing by the new Vitek 2 AST-YS06 yeast card using a unique collection of FKS wild-type and hot spot mutant isolates, including the five most common candida species

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Correlation of susceptibility of Cryptococcus neoformans to amphotericin B with clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Azole-resistance in Aspergillus: proposed nomenclature and breakpoints

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Investigation of the potential relationships between plasma voriconazole concentrations and visual adverse events or liver function test abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Using pathology-specific laboratory profiles in clinical pathology to reduce inappropriate test requesting: two completed audit cycles

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

A simple method for detecting subcutaneous phaeohyphomycosis with light-colored fungi. A study of eight cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Histopathology of experimental Aspergillus fumigatus keratitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Histopathologic diagnosis of fungal infections in the 21st century

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Development of molecular methods for the identification of aspergillus and emerging moulds in paraffin wax embedded tissue sections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Comparison of histopathological analysis, culture, and polymerase chain reaction assays to detect invasive mold infections from biopsy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Comparison of quantitative real time PCR with Sequencing and ribosomal RNA-FISH for the identification of fungi in formalin fixed, paraffin-embedded tissue specimens.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Detection of Aspergillus in lung and other tissue samples using the MycAssay Aspergillus real-time PCR kit.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Early chest radiography and CT in the diagnosis, management and outcome of invasive pulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Pulmonary infections after bone marrow transplantation: clinical and radiographic findings.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Pneumocystis carinii pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

High-resolution ultrafast chest CT in the clinical management of febrile bone marrow transplant patients with normal or nonspecific chest roentgenograms

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Early detection of pneumonia in febrile neutropenic patients: use of thin-section CT.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: use of high-resolution computed tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Pulmonary infections in the late period after allogeneic bone marrow transplantation: chest radiography versus computed tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Pulmonary infections after bone marrow transplantation: high-resolution CT findings in 111 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Comparison of CT features of Aspergillus and bacterial pneumonia in severely neutropenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Imaging features of invasive and noninvasive fungal sinusitis: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

An approach to fulminant invasive fungal rhinosinusitis in the immunocompromised host

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Incremental benefit of maximum-intensity-projection images on observer detection of small pulmonary nodules revealed by multidetector CT.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Direct detection of angioinvasive pulmonary aspergillosis in immunosuppressed patients: preliminary results with high-resolution 16-MDCT angiography

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Cerebral aspergillosis: radiologic and pathologic findings

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Aspergillosis of the brain and paranasal sinuses in immunocompromised patients: CT and MR imaging findings

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

Brain parenchymal infection in bone marrow transplantation patients: CT and MR findings.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970006-X

7 January 2021

10.1016/S1473-3099(15)70006-X

Identifiers

DOI

1 reference

2 September 2017

1 reference